Skip to main content

Pennant Reports Fourth Quarter and Fiscal Year 2023 Results

EAGLE, Idaho, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the fiscal year and fourth quarter of 2023, reporting GAAP diluted earnings per share of $0.44 and $0.14 for the year ended December 31, 2023 and the fourth quarter, respectively. Pennant also reported adjusted diluted earnings per share of $0.73 for the year and $0.22 for the quarter (1).

Fourth Quarter Highlights

  • Total revenue for the full year was $544.9 million, an increase of $71.7 million or 15.1% over the prior year, and for the quarter was $146.0 million, an increase of $21.3 million or 17.1% over the prior year quarter;
  • Net income for the full year was $13.4 million, an increase of $6.7 million or 101.4% over the prior year and for the fourth quarter was $4.3 million, an increase of $0.9 million or 25.2% over the prior year quarter;
  • Adjusted net income for the full year was $21.9 million, an increase of $4.8 million or 28.3% over the prior year and for the fourth quarter was $6.6 million, an increase of $1.2 million or 22.2% over the prior year quarter;
  • Segment Adjusted EBITDAR from Operations for the full year was $79.2 million, an increase of $11.2 million or 16.5% over the prior year and for the fourth quarter was $21.9 million, an increase of $2.8 million or 14.7% over the prior year quarter;
  • Adjusted EBITDA for the full year was $40.7 million, an increase of $9.2 million or 29.1% over the prior year and for the fourth quarter was $11.9 million, an increase of $2.0 million or 19.8% over the prior year quarter;
  • Home Health and Hospice Services segment revenue for the full year 2023 was $394.5 million, an increase of $52.2 million or 15.3% over the prior year and for the fourth quarter was $106.9 million, an increase of $16.2 million or 17.9% over the prior year quarter;
  • Home Health and Hospice Services segment adjusted EBITDAR from operations for the full year was $65.6 million, an increase of $3.8 million or 6.1% over prior year and for the fourth quarter was $18.2 million, an increase of $1.5 million or 8.8% over the prior year quarter; and segment adjusted EBITDA from operations the full year was $60.1 million, an increase of $3.2 million or 5.5% over the prior year and for the fourth quarter was $16.7 million, an increase of $1.1 million or 7.3% over the prior year quarter;
  • Total home health admissions for the the full year were 43,508, an increase of 3,072 or 7.6% over the prior year and fourth quarter were 11,328, an increase of 1,281 or 12.8% over the prior year quarter; total Medicare home health admissions for the full year were 19,389, an increase of 748 or 4.0% over the prior year and for the fourth quarter were 4,952, an increase of 263 or 5.6% over the prior year quarter;
  • Hospice average daily census for the full year was 2,607, an increase of 311 or 13.5% over prior year and for the fourth quarter was 2,796, an increase of 423 or 17.8% compared to the prior year quarter;
  • Senior Living Services segment revenue for the full year was $150.4 million, an increase of $19.4 million or 14.8% over prior year and for the fourth quarter was $39.1 million, an increase of $5.0 million or 14.8% over the prior year quarter; average occupancy for the fourth quarter was 79.0%, an increase of 130 basis points over the prior year quarter, and average monthly revenue per occupied room for the fourth quarter was $4,093 an increase of $423 or 11.5% over the prior year quarter;
  • Same store(2) Senior Living Services segment revenue for the full year was $145.0 million, an increase of $18.2 million or 14.4% over the prior year and for the fourth quarter was $37.2 million, an increase of $3.7 million or 11.1% over the prior year quarter; same store senior living average occupancy for the fourth quarter was 79.9%, an increase of 130 basis points over the prior year quarter, and average monthly revenue per occupied room for the fourth quarter was $4,068 an increase of $398 or 10.8% over the prior year quarter;
  • Senior Living segment adjusted EBITDAR from operations for the full year was $45.3 million, an increase of $7.7 million or 20.6% over the prior year and for the fourth quarter was $11.9 million, an increase of $1.9 million or 19.1% over the prior year quarter; and segment adjusted EBITDA from Operations for the full year was $12.3 million, an increase of $6.3 million or 104.8% over the prior year and for the fourth quarter was $3.4 million, an increase of $1.4 million or 69.4% over the prior year quarter.
 (1) See "Reconciliation of GAAP to Non-GAAP Financial Information.”
 (2) “Same store Senior Living Services” is defined as all senior living communities excluding those transferred to Ensign and new senior living operations acquired in 2022 or 2023.

Operating Results

“We are pleased with our strong finish to 2023 and continued momentum as we enter 2024,” said Brent Guerisoli, Pennant’s Chief Executive Officer. “By executing on our five key focus areas--leadership development, clinical excellence, employee engagement, margin improvement, and growth--we made steady gains throughout 2023 and solidly delivered on earnings expectations, even after increasing guidance during the year. With a talented group of leaders and teams in operations throughout our footprint and compelling growth opportunities available to us, we are excited to accelerate our performance in 2024.”

Lynette Walbom, Pennant’s Chief Financial Officer, commented on the Company’s balance sheet and strong cash flow: “Our operations produced $33.1 million of cash through the fourth quarter, which positions us well to respond to growth opportunities in 2024 and beyond.” She noted that the Company had $6.1 million of cash on hand and $80.8 million available on its revolving line of credit, with a net debt-to-adjusted EBITDA ratio of 1.44x and a lease-adjusted net debt-to-adjusted EBITDAR ratio of 4.75x.

A discussion of the Company's use of Non-GAAP financial measures is set forth below. A reconciliation of net income to EBITDA, adjusted EBITDAR and adjusted EBITDA, as well as a reconciliation of GAAP earnings per share, net income to adjusted net earnings per share and adjusted net income, appear in the financial data portion of this release. More complete information is contained in the Company’s Form 10-K for the year ended December 31, 2023, which has been filed with the SEC today and can be viewed on the Company’s website at www.pennantgroup.com.

2024 Guidance

Management is providing 2024 annual guidance as follows: total revenue is anticipated to be between $596.8 million and $633.7 million; adjusted earnings per diluted share is anticipated to be between $0.82 and $0.91; and adjusted EBITDA is anticipated to be between $46.2 million and $49.7 million.

Mr. Guerisoli remarked, “Our earnings guidance midpoint of $0.87 represents 19.2% growth on our 2023 adjusted earnings per share and 52.6% growth over our 2022 results. This demonstrates, and is based on, the compelling momentum in both our segments, the readiness of our local leaders to drive organic and inorganic growth, and the latent potential that remains in our existing operations.”

The Company does not provide quarterly earnings guidance. Consistent with the Company’s historical patterns, Management anticipates that total revenue, adjusted earnings per diluted share, and adjusted EBITDA will increase each quarter throughout the year, creating a ramp rather than a uniform distribution over the course of 2024.

The Company’s 2024 annual guidance is based on diluted weighted average shares outstanding of approximately 30.4 million and a 26.0% effective tax rate. The guidance assumes, among other things, reimbursement rate adjustments and no unannounced acquisitions. It excludes the tax-effected costs at start-up operations, share-based compensation, acquisition-related costs, and loss on disposition of assets and impairments. The guidance includes anticipated revenues from the Muir Home Health joint venture which commenced January 1, 2024, but, consistent with the start-up nature of the venture, assumes no earnings contributions in 2024.

Ms. Walbom stated, “We believe providing annual adjusted consolidated EBITDA guidance in addition to annual revenue and adjusted earnings per share guidance is helpful in understanding our expectations for our business and operational cash flow. This updated guidance reflects management’s expectations based on 2023 performance and current operating conditions.”

Conference Call

A live webcast will be held tomorrow, February 29, 2024 at 10:00 a.m. Mountain time (12:00 p.m. Eastern time) to discuss Pennant’s fourth quarter 2023 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Pennant’s website at https://investor.pennantgroup.com. The webcast will be recorded and will be available for replay via the website.

About Pennant

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 111 home health and hospice agencies and 51 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and/or 10-K, for a more complete discussion of the risks and other factors that could affect Pennant’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Pennant does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

SOURCE: The Pennant Group, Inc.

THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(unaudited, in thousands, except for per-share amounts)
 
 Three Months Ended December 31, Year Ended December 31,
  2023   2022   2023   2022 
        
Revenue$145,954  $124,665  $544,891  $473,241 
        
Expense:       
Cost of services 116,934   98,980   438,096   376,638 
Rent—cost of services 10,320   9,498   39,759   38,018 
General and administrative expense 9,754   8,328   36,667   33,981 
Depreciation and amortization 1,313   1,223   5,130   4,900 
Loss on asset dispositions and impairment, net 66   252   70   6,965 
Total expenses 138,387   118,281   519,722   460,502 
Income from operations 7,567   6,384   25,169   12,739 
Other income (expense), net:       
Other income (expense) 311   19   339   (31)
Interest expense, net (1,569)  (1,308)  (5,924)  (3,816)
Other expense, net (1,258)  (1,289)  (5,585)  (3,847)
Income before provision for income taxes 6,309   5,095   19,584   8,892 
Provision for income taxes 1,780   1,408   5,674   1,649 
Net income 4,529   3,687   13,910   7,243 
Less: net income attributable to noncontrolling interest 180   213   531   600 
Net income and other comprehensive income attributable to The Pennant Group, Inc.$4,349  $3,474  $13,379  $6,643 
Earnings per share:       
Basic$0.15  $0.12  $0.45  $0.23 
Diluted$0.14  $0.12  $0.44  $0.22 
Weighted average common shares outstanding:       
Basic 29,978   29,728   29,863   29,064 
Diluted 30,236   30,091   30,193   30,159 
                


THE PENNANT GROUP, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except par value)
 
 December 31, 2023 December 31, 2022
Assets   
Current assets:   
Cash$6,059  $2,079 
Accounts receivable—less allowance for doubtful accounts of $259 and $592, respectively 61,116   53,420 
Prepaid expenses and other current assets 12,902   18,323 
Total current assets 80,077   73,822 
Property and equipment, net 28,598   26,621 
Right-of-use assets 262,923   260,868 
Deferred tax assets, net    2,149 
Restricted and other assets 9,337   10,545 
Goodwill 91,014   79,497 
Other indefinite-lived intangibles 67,742   58,617 
Total assets$539,691  $512,119 
Liabilities and equity   
Current liabilities:   
Accounts payable$10,841  $13,647 
Accrued wages and related liabilities 28,256   23,283 
Lease liabilities—current 17,122   16,633 
Other accrued liabilities 15,330   16,684 
Total current liabilities 71,549   70,247 
Long-term lease liabilities—less current portion 248,596   247,042 
Deferred tax liabilities, net 1,855    
Other long-term liabilities 8,262   6,281 
Long-term debt, net 63,914   62,892 
Total liabilities 394,176   386,462 
Equity:   
Common stock, $0.001 par value; 100,000 shares authorized; 30,297 and 29,948 shares issued and outstanding at December 31, 2023, respectively, and 30,149 and 29,692 shares issued and outstanding at December 31, 2022, respectively 29   29 
Additional paid-in capital 105,712   99,764 
Retained earnings 34,663   21,284 
Treasury stock, at cost, 3 shares at December 31, 2023 and 2022 (65)  (65)
Total The Pennant Group, Inc. stockholders’ equity 140,339   121,012 
Noncontrolling interest 5,176   4,645 
Total equity 145,515   125,657 
Total liabilities and equity$539,691  $512,119 
        


THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:

 Year Ended December 31,
  2023   2022 
Net cash provided by operating activities$33,090  $9,044 
Net cash used in investing activities (30,222)  (24,239)
Net cash provided by financing activities 1,112   12,084 
Net increase (decrease) in cash 3,980   (3,111)
Cash beginning of period 2,079   5,190 
Cash end of period$6,059  $2,079 
        


THE PENNANT GROUP, INC.
REVENUE BY SEGMENT
(unaudited, dollars in thousands)

The following table sets forth our total revenue by segment and as a percentage of total revenue for the periods indicated:

 Three Months Ended December 31,
  2023   2022 
 Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage
        
Home health and hospice services       
Home health$45,932   31.5% $41,896   33.6%
Hospice 54,405   37.3   42,816   34.3 
Home care and other(a) 6,554   4.5   5,939   4.8 
Total home health and hospice services 106,891   73.3   90,651   72.7 
Senior living services 39,063   26.7   34,014   27.3 
Total revenue$145,954   100.0% $124,665   100.0%


(a) Home care and other revenue is included with home health revenue in other disclosures in this press release.
   


 Year Ended December 31,
  2023   2022 
 Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage
        
Home health and hospice services       
Home health$175,044   32.1% $159,858   33.8%
Hospice 194,627   35.7   160,520   33.9 
Home care and other(a) 24,793   4.6   21,871   4.6 
Total home health and hospice services 394,464   72.4   342,249   72.3 
Senior living services 150,427   27.6   130,992   27.7 
Total revenue$544,891   100.0% $473,241   100.0%


(a) Home care and other revenue is included with home health revenue in other disclosures in this press release.
   


THE PENNANT GROUP, INC.
SELECT PERFORMANCE INDICATORS
(unaudited, total revenue dollars in thousands)

The following table summarizes our overall home health and hospice performance indicators for the each of the dates or periods indicated:

 Three Months Ended December 31,    
  2023   2022  Change % Change
Total agency results:        
Home health and hospice revenue$106,891  $90,651   16,240   17.9%
        
Home health services:       
Total home health admissions 11,328   10,047   1,281   12.8%
Total Medicare home health admissions 4,952   4,689   263   5.6%
Average Medicare revenue per 60-day completed episode(a)$3,573  $3,497  $76   2.2%
Hospice services:       
Total hospice admissions 2,540   2,246   294   13.1%
Average daily census 2,796   2,373   423   17.8%
Hospice Medicare revenue per day$189  $182  $7   3.8%
                


 Three Months Ended December 31,    
  2023   2022  Change % Change
Same agency(b) results:        
Home health and hospice revenue$97,746  $88,519  $9,227   10.4%
        
Home health services:       
Total home health admissions 10,617   9,792   825   8.4%
Total Medicare home health admissions 4,515   4,498   17   0.4%
Average Medicare revenue per 60-day completed episode(a)$3,601  $3,505  $96   2.7%
Hospice services:       
Total hospice admissions 2,232   2,196   36   1.6%
Average daily census 2,530   2,308   222   9.6%
Hospice Medicare revenue per day$187  $183  $4   2.2%
                


 Year Ended December 31,    
  2023   2022  Change % Change
Total agency results:        
Home health and hospice revenue$394,464  $342,249  $52,215   15.3%
        
Home health services:       
Total home health admissions 43,508   40,436   3,072   7.6%
Total Medicare home health admissions 19,389   18,641   748   4.0%
Average Medicare revenue per 60-day completed episode(a)$3,533  $3,531  $2   0.1%
Hospice services:       
Total hospice admissions 9,746   9,166   580   6.3%
Average daily census 2,607   2,296   311   13.5%
Hospice Medicare revenue per day$185  $178  $7   3.9%
                


 Year Ended December 31,    
  2023   2022  Change % Change
Same agency(b) results:        
Home health and hospice revenue$372,620  $338,824  $33,796   10.0%
        
Home health services:       
Total home health admissions 41,173   40,041   1,132   2.8%
Total Medicare home health admissions 17,888   18,358   (470)  (2.6)%
Average Medicare revenue per 60-day completed episode(a)$3,557  $3,534  $23   0.7%
Hospice services:       
Total hospice admissions 8,999   8,917   82   0.9%
Average daily census 2,460   2,276   184   8.1%
Hospice Medicare revenue per day$186  $179  $7   3.9%


(a) The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
(b) Same agency results represent all agencies purchased or licensed prior to January 1, 2022.

The following table summarizes our senior living performance indicators for the periods indicated:

 Three Months Ended December 31, Year Ended December 31,
  2023   2022   2023   2022 
Total senior living results:       
Senior living revenue$39,063  $34,014  $150,427  $130,992 
        
Occupancy 79.0%  77.7%  78.5%  75.7%
Average monthly revenue per occupied unit$4,093  $3,670  $3,969  $3,516 
                


 Three Months Ended December 31, Year Ended December 31,
  2023   2022   2023   2022 
Same store senior living(a) results:        
Senior living revenue$37,226  $33,506  $144,969  $126,758 
        
Occupancy 79.9%  78.6%  79.7%  77.2%
Average monthly revenue per occupied unit$4,068  $3,670  $3,956  $3,583 


(a) Same store senior living results is defined as all senior living communities excluding those transferred to Ensign and new senior living operations acquired in 2022 or 2023.


THE PENNANT GROUP, INC.
REVENUE BY PAYOR SOURCE
(unaudited, dollars in thousands)

The following table presents our total revenue by payor source as a percentage of total revenue for the periods indicated:

  Three Months Ended December 31,
   2023   2022 
  Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage
         
Revenue:        
Medicare $70,915   48.6% $60,570   48.6%
Medicaid  20,882   14.3   16,854   13.5 
Subtotal  91,797   62.9   77,424   62.1 
Managed Care  20,210   13.8   16,996   13.6 
Private and Other(a)  33,947   23.3   30,245   24.3 
Total revenue $145,954   100.0% $124,665   100.0%


(a) Private and other payors in our home health and hospice services segment includes revenue from all payors generated in home care operations.


  Year Ended December 31,
   2023   2022 
  Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage
         
Revenue:        
Medicare $263,810   48.4% $231,753   49.0%
Medicaid  77,337   14.2   62,934   13.3 
Subtotal  341,147   62.6   294,687   62.3 
Managed Care  73,748   13.5   62,101   13.1 
Private and Other(a)  129,996   23.9   116,453   24.6 
Total revenue $544,891   100.0% $473,241   100.0%


(a) Private and other payors in our home health and hospice services segment includes revenue from all payors generated in home care operations.


THE PENNANT GROUP, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(unaudited, in thousands, except per share data)

The following table reconciles net income to Non-GAAP net income for the periods presented:

 Three Months Ended December 31, Year Ended December 31,
  2023   2022   2023   2022 
        
Net income attributable to The Pennant Group, Inc.$4,349  $3,474  $13,379  $6,643 
        
Non-GAAP adjustments       
Net income attributable to noncontrolling interest(a)          224 
Costs at start-up operations(b) 102   777   1,162   2,112 
Share-based compensation expense(c) 1,401   1,044   5,565   3,363 
Acquisition related costs and credit allowances(d) 301   (283)  476   731 
Costs associated with transitioning operations(e) 102   25   861   7,051 
Unusual, non-recurring or redundant charges(f) 942   927   2,575   1,297 
Provision for income taxes on Non-GAAP adjustments(g) (562)  (533)  (2,124)  (4,353)
Non-GAAP net income$6,635  $5,431  $21,894  $17,068 
        
Dilutive Earnings Per Share As Reported       
Net Income$0.14  $0.12  $0.44  $0.22 
Average number of shares outstanding 30,236   30,091   30,193   30,159 
        
Adjusted Diluted Earnings Per Share        
Net Income$0.22  $0.18  $0.73  $0.57 
Average number of shares outstanding 30,236   30,091   30,193   30,159 


(a) Effective the three months ended September 30, 2022 we updated our definition of non-GAAP net income to exclude an adjustment for net income attributable to noncontrolling interest.
          
(b) Represents results related to start-up operations.
   Three Months Ended December 31, Year Ended December 31,
    2023   2022   2023   2022 
  Revenue$(2,216) $(2,301) $(11,037) $(5,742)
  Cost of services 2,158   2,798   11,139   7,177 
  Rent 156   274   1,041   660 
  Depreciation & amortization 4   6   19   17 
  Total Non-GAAP adjustment$102  $777  $1,162  $2,112 
          
(c) Represents share-based compensation expense incurred for the periods presented.
   Three Months Ended December 31, Year Ended December 31,
    2023   2022   2023   2022 
  Cost of services$832  $644  $3,120  $2,439 
  General and administrative 569   400   2,445   924 
  Total Non-GAAP adjustment$1,401  $1,044  $5,565  $3,363 
          
(d) Represents costs incurred to acquire an operation that are not capitalizable.


(e) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is actively seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign.

During January 2022, affiliates of the Company entered into Transfer Agreements with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the “Transaction”) from affiliates of the Company to affiliates of Ensign. The closing of the Transaction was completed in two phases with the transfer of two operations on March 1, 2022 and the remainder transferred on April 1, 2022. The amount above represents the net impact on revenue and cost of service attributable to all of the transferred entities. The amounts reported exclude rent and depreciation and amortization expense related to such operations.
   
   Three Months Ended December 31, Year Ended December 31,
    2023   2022   2023   2022 
  Revenue$  $5  $(4) $(3,370)
  Cost of services 17   20   616   2,755 
  Rent 82      238   948 
  Depreciation 3      11    
  Loss on asset dispositions and impairment          6,718 
  Total Non-GAAP adjustment$102  $25  $861  $7,051 
          
(f) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses. The amounts reported for the year ended December 31, 2022 include certain costs identified as redundant or non-recurring incurred by the Company for services provided by Ensign under the Transition Services Agreement, and were included in general and administrative expense.
          
(g) Represents an adjustment to the provision for income tax to our year-to-date effective tax rate of 25.8% and 25.6% for the year ended December 31, 2023 and 2022, respectively. This rate excludes the tax benefit of shared-based payment awards.
   

The table below reconciles Consolidated net income to the Consolidated Non-GAAP financial measures, Consolidated Adjusted EBITDA, and to the Non-GAAP valuation measure, Consolidated Adjusted EBITDAR, for the periods presented:

 Three Months Ended December 31, Year Ended December 31,
  2023   2022   2023   2022 
        
Consolidated net income$4,529  $3,687  $13,910  $7,243 
Less: Net income attributable to noncontrolling interest 180   213   531   600 
Add: Provision for income taxes 1,780   1,408   5,674   1,649 
Net interest expense 1,569   1,308   5,924   3,816 
Depreciation and amortization 1,313   1,223   5,130   4,900 
Consolidated EBITDA 9,011   7,413   30,107   17,008 
Adjustments to Consolidated EBITDA       
Add: Costs at start-up operations(a) (58)  497   102   1,435 
Share-based compensation expense(b) 1,401   1,044   5,565   3,363 
Acquisition related costs and credit allowances(c) 301   (283)  476   731 
Costs associated with transitioning operations(d) 17   25   612   6,103 
Unusual, non-recurring or redundant charges(e) 942   927   2,575   1,297 
Rent related to items (a) and (d) above 238   274   1,279   1,608 
Consolidated Adjusted EBITDA 11,852   9,897   40,716   31,545 
Rent—cost of services 10,320   9,498   39,759   38,018 
Rent related to items (a) and (d) above (238)  (274)  (1,279)  (1,608)
Adjusted rent—cost of services 10,082   9,224   38,480   36,410 
Consolidated Adjusted EBITDAR(f)$21,934    $79,196   


(a) Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.
(b) Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(c) Non-capitalizable costs associated with acquisitions, credit allowances, and write offs for amounts in dispute with the prior owners of certain acquired operations.
(d) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is actively seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign.

During January 2022, affiliates of the Company entered into Transfer Agreements with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the “Transaction”) from affiliates of the Company to affiliates of Ensign. The closing of the Transaction was completed in two phases with the transfer of two operations on March 1, 2022 and the remainder transferred on April 1, 2022. The amount above represents the net impact on revenue and cost of service attributable to all of the transferred entities. The amounts reported exclude rent and depreciation and amortization expense related to such operations.
(e) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses. The amounts reported for the year ended December 31, 2022 include certain costs identified as redundant or non-recurring incurred by the Company for services provided by Ensign under the Transition Services Agreement, and were included in general and administrative expense.
(f) This measure is a valuation measure and is displayed thusly, it is not a performance measure as it excludes rent expense, which is a normal and recurring operating expense and, as such, does not reflect our cash requirements for leasing commitments. Our presentation of Consolidated Adjusted EBITDAR should not be construed as a financial performance measure.
   

The following table present certain financial information regarding our reportable segments. General and administrative expenses are not allocated to the reportable segments and are included in “All Other”:

 Home Health and Hospice Services Senior Living Services All Other Total
Segment GAAP Financial Measures:       
Three Months Ended December 31, 2023       
Revenue$106,891  $39,063  $  $145,954 
Segment Adjusted EBITDAR from Operations$18,242  $11,900  $(8,208) $21,934 
Three Months Ended December 31, 2022       
Revenue$90,651  $34,014  $  $124,665 
Segment Adjusted EBITDAR from Operations$16,771  $9,990  $(7,640) $19,121 


 Home Health and Hospice Services Senior Living Services All Other Total
Segment GAAP Financial Measures:       
Year Ended December 31, 2023       
Revenue$394,464  $150,427  $  $544,891 
Segment Adjusted EBITDAR from Operations$65,606  $45,294  $(31,704) $79,196 
Year Ended December 31, 2022       
Revenue$342,249  $130,992  $  $473,241 
Segment Adjusted EBITDAR from Operations$61,827  $37,563  $(31,435) $67,955 
                

The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to Condensed Consolidated Income from Operations:

 Three Months Ended December 31, Year Ended December 31,
  2023   2022   2023   2022 
        
Segment Adjusted EBITDAR from Operations(a)$21,934  $19,121  $79,196  $67,955 
Less: Depreciation and amortization 1,313   1,223   5,130   4,900 
Rent—cost of services 10,320   9,498   39,759   38,018 
Other income (expense) 311   19   339   (31)
Adjustments to Segment EBITDAR from Operations:       
Less: Costs at start-up operations(b) (58)  497   102   1,435 
Share-based compensation expense(c) 1,401   1,044   5,565   3,363 
Acquisition related costs and credit allowances(d) 301   (283)  476   731 
Costs associated with transitioning operations(e) 17   25   612   6,103 
Unusual, non-recurring or redundant charges(f) 942   927   2,575   1,297 
Add: Net income attributable to noncontrolling interest 180   213   531   600 
Consolidated Income from Operations$7,567  $6,384  $25,169  $12,739 


(a) Segment Adjusted EBITDAR from Operations is net income (loss) attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation, (3) acquisition related costs and credit allowances, (4) the costs associated with transitioning operations, (5) unusual, non-recurring or redundant charges, and (6) net income attributable to noncontrolling interest. General and administrative expenses are not allocated to the reportable segments, and are included as “All Other”, accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited.
(b) Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.
(c) Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(d) Non-capitalizable costs associated with acquisitions, credit allowances, and write offs for amounts in dispute with the prior owners of certain acquired operations.
(e) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is actively seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign.

During January 2022, affiliates of the Company entered into Transfer Agreements with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the “Transaction”) from affiliates of the Company to affiliates of Ensign. The closing of the Transaction was completed in two phases with the transfer of two operations on March 1, 2022 and the remainder transferred on April 1, 2022. The amount above represents the net impact on revenue and cost of service attributable to all of the transferred entities. The amounts reported exclude rent and depreciation and amortization expense related to such operations.
(f) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses. The amounts reported for the year ended December 31, 2022 include certain costs identified as redundant or non-recurring incurred by the Company for services provided by Ensign under the Transition Services Agreement, and were included in general and administrative expense.
   

The tables below reconcile Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for each reportable segment for the periods presented:

 Three Months Ended December 31,
 Home Health and Hospice Senior Living
  2023   2022   2023   2022 
        
Segment Adjusted EBITDAR from Operations$18,242  $16,771  $11,900  $9,990 
Less: Rent—cost of services 1,655   1,295   8,664   8,203 
Rent related to start-up and transitioning operations (65)  (49)  (173)  (225)
Segment Adjusted EBITDA from Operations$16,652  $15,525  $3,409  $2,012 


 Year Ended December 31,
 Home Health and Hospice Senior Living
  2023   2022   2023   2022 
        
Segment Adjusted EBITDAR from Operations$65,606  $61,827  $45,294  $37,563 
Less: Rent—cost of services 5,791   5,060   33,967   32,958 
Rent related to start-up and transitioning operations (313)  (210)  (966)  (1,398)
Segment Adjusted EBITDA from Operations$60,128  $56,977  $12,293  $6,003 
                

Discussion of Non-GAAP Financial Measures

EBITDA consists of net income before (a) interest expense, net, (b) (benefits) provisions for income taxes, and (c) depreciation and amortization. Adjusted EBITDA consists of net income attributable to the Company before (a) interest expense, net (b) (benefits) provisions for income taxes, (c) depreciation and amortization, (d) costs incurred for start-up operations, including rent and excluding depreciation, interest and income taxes, (e) share-based compensation expense, (f) non-capitalizable acquisition related costs and credit allowances, (g) net costs associated with transitioning operations, (h) unusual, non-recurring or redundant charges and (i) net income attributable to noncontrolling interest. Consolidated Adjusted EBITDAR is a valuation measure applicable to current periods only and consists of net income attributable to the Company before (a) interest expense, net, (b) (benefits) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) costs incurred for start-up operations, excluding rent, depreciation, interest and income taxes, (f) share-based compensation expense, (g) acquisition related costs and credit allowances, (h) redundant or non-recurring transition services costs, (i) costs associated with transitioning operations, (j) unusual, non-recurring or redundant charges and (j) net income attributable to noncontrolling interest. The company believes that the presentation of EBITDA, adjusted EBITDA, consolidated adjusted EBITDAR, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. The company believes disclosure of adjusted net income, adjusted net income per share, EBITDA, adjusted EBITDA and consolidated adjusted EBITDAR has economic substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measure provides useful information to investors, the specific manner in which management uses this measure, and some of the limitations associated with the use of this measure, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Pennant’s website at http://www.pennantgroup.com.


Contact Information

Investor Relations
The Pennant Group, Inc.
(208) 506-6100
ir@pennantgroup.com

Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.